P022 Impaired clonogenic and proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes

Emilia Stavroulaki, Helen Α. Papadaki(University of Crete), Maria-Christina Kastrinaki, Athanasios Galanopoulos, G. Gvazava(University of Crete), Verónica Papa, Maria Ximeri(University of Crete), Athina-Nora Viniou, Christina Kalpadaki, M. Klaus, Maria Psyllaki(University of Crete), George D. Eliopoulos(University of Crete), Agapi Parcharidou

Leukemia Research

May 1, 2007

10.1016/s0145-2126(07)70092-9

Cited by 0

Related Papers

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2

|Nature Genetics|2003|389

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapy

|Blood|2002|266

Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis

|Annals of the Rheumatic Diseases|2007|154

Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha–mediated effect

|Blood|2002|138

Multicentric Castleman's disease

|AIDS|2004|121